R-Crizotinib predisposes to and exacerbates pulmonary arterial hypertension in animal models

Eur Respir J. 2021 May 13;57(5):2003271. doi: 10.1183/13993003.03271-2020. Print 2021 May.

Charifa Awada¹, Yann Grobs¹, Wen-Hui Wu^{1

2}, Karima Habbout¹, Charlotte Romanet¹, Sandra Breuils-Bonnet¹, Eve Tremblay¹, Sandra Martineau¹, Roxane Paulin^{1

3}, Sébastien Bonnet^{1

3}, Steeve Provencher^{1

3}, François Potus^{1

3

4}, Olivier Boucherat^{5

3

4}

¹ Pulmonary Hypertension Research Group, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, QC, Canada.
² Dept of Cardio-Pulmonary Circulation, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
³ Dept of Medicine, Université Laval, Québec City, QC, Canada.
⁴ F. Potus and O. Boucherat contributed equally to this article as lead authors and supervised the work.
⁵ Pulmonary Hypertension Research Group, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, QC, Canada olivier.boucherat@criucpq.ulaval.ca.

No abstract available

Publication types